Product Information
SYNJARDY XR 25-1,000 MG TABLET is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $11.1941 per EA under NDC 00597029578. Its NADAC has been published 445 times since Dec 20, 2017.
Strength
25; 1000 mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597029578
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA208658On Market Since
12/10/2016
Pharmacological Classes
Price Statistics
The NADAC for SYNJARDY XR 25-1,000 MG TABLET has been published 445 times since Dec 20, 2017, and over the history we have for it it has declined 19.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.1941 per EA |
|---|---|
| All-time high | $20.1486 (Dec 31, 2025) |
| All-time low | $11.1883 (May 20, 2026) |
| 52-week high | $20.1486 |
| 52-week low | $11.1883 |
| Median price | $17.5189 |
| Average price | $17.3413 |
| Largest weekly change | -44.4% (Jan 7, 2026) |
| Weeks tracked | 445 |
| Tracking since | Dec 20, 2017 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SYNJARDY XR 25-1,000 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SYNJARDY XR 25-1,000 MG TABLET, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $11.1941 per EA (NDC 00597029578), effective Jun 24, 2026.
How has the price of SYNJARDY XR 25-1,000 MG TABLET changed over time?
Over the history we have for it, the NADAC for SYNJARDY XR 25-1,000 MG TABLET has declined 19.6%. It has been tracked across 445 weekly CMS publications since Dec 20, 2017.
What are the highest and lowest recorded NADAC prices for SYNJARDY XR 25-1,000 MG TABLET?
Since Dec 20, 2017, the NADAC for SYNJARDY XR 25-1,000 MG TABLET has ranged from a low of $11.1883 (May 20, 2026) to a high of $20.1486 (Dec 31, 2025), with a median of $17.5189 per EA.
Are there cheaper alternatives to SYNJARDY XR 25-1,000 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SYNJARDY XR 25-1,000 MG TABLET, but none are currently priced below it.
Who manufactures SYNJARDY XR 25-1,000 MG TABLET?
SYNJARDY XR 25-1,000 MG TABLET (NDC 00597029578) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification